Stock News

Banced Has Raised Its Merck & Co (MRK) Position by $802,386 as Stock Value Rose; Chevrontexaco (CVX) Stake Maintained by Kahn Brothers Group Inc

Merck & Co., Inc. (NYSE:MRK) Logo

Irving Kahn increased its stake in Chevrontexaco (CVX) by 24.7% based on its latest 2018Q1 regulatory filing with the SEC. Kahn Brothers Group Inc bought 1,000 shares as the company’s stock rose 6.62% while stock markets declined. The hedge fund run by Irving Kahn held 5,048 shares of the integrated oil company at the end of 2018Q1, valued at $575.67 million, up from 4,048 at the end of the previous reported quarter. Kahn Brothers Group Inc who had been investing in Chevrontexaco for a number of months, seems to be bullish on the $239.06 billion market cap company. The stock increased 2.05% or $2.51 during the last trading session, reaching $125.1. About 8.91M shares traded or 31.72% up from the average. Chevron Corporation (NYSE:CVX) has risen 16.25% since June 24, 2017 and is uptrending. It has outperformed by 3.68% the S&P500. Some Historical CVX News: 12/04/2018 – CHEVRON, EXXON MOBIL ARE SAID TO ASK FOR BIOFUEL WAIVERS: RTRS; 06/03/2018 – CHEVRON – EVEN WITH NO COMMODITY PRICE APPRECIATION, EXPECT TO DELIVER “STRONGER” UPSTREAM CASH MARGINS, PRODUCTION GROWTH IN 2018; 17/04/2018 – FoodEnvReportingNet: Sources say Chevron and Exxon Mobil have asked the EPA for a hardship waiver from the ethanol mandate; 30/04/2018 – CHEVRON PRESIDENT JEFF SHELLEBARGER SPEAKS AT OTC PRESENTATION; 26/03/2018 – CHEVRON CORP’S CVX.N JOHNSON SAYS DID NOT HAVE A LOT OF ‘TRAPPED CASH’ OVERSEAS BEFORE U.S. TAX OVERHAUL; 31/03/2018 – Cal EMA Spills: SPILL Report – Chevron – 03/31/2018 08:04 PM; 14/04/2018 – Venezuela empowers oil minister Quevedo to reform energy sector; 20/04/2018 – INDONESIA’S PERTAMINA HAS SIGNED AGREEMENTS TO TAKE OVER 8 EXPIRING OIL BLOCKS PREVIOUSLY HELD BY CHEVRON AND INPEX, AMONG OTHERS -ENERGY MINISTRY; 26/04/2018 – The Next Steps for Chevron’s Drilling Technology (Video); 12/04/2018 – Sempra’s Mexican Unit Ienova to Store Fuel for Chevron

Banced Corp increased its stake in Merck & Co Inc (MRK) by 289.88% based on its latest 2018Q1 regulatory filing with the SEC. Banced Corp bought 14,859 shares as the company’s stock rose 5.40% while stock markets declined. The institutional investor held 19,985 shares of the health care company at the end of 2018Q1, valued at $1.09M, up from 5,126 at the end of the previous reported quarter. Banced Corp who had been investing in Merck & Co Inc for a number of months, seems to be bullish on the $165.37 billion market cap company. The stock increased 0.47% or $0.29 during the last trading session, reaching $61.47. About 12.91 million shares traded or 15.64% up from the average. Merck & Co., Inc. (NYSE:MRK) has declined 9.15% since June 24, 2017 and is downtrending. It has underperformed by 21.72% the S&P500. Some Historical MRK News: 27/03/2018 – U.S. FOOD AND DRUG ADMINISTRATION (FDA) ACCEPTS BRISTOL-MYERS SQUIBB’S APPLICATION FOR OPDIVO (NIVOLUMAB) PLUS YERVOY (IPILIMUMAB) FOR PREVIOUSLY TREATED PATIENTS WITH MSI-H OR DMMR METASTATIC COLORECTA; 30/04/2018 – Merck: FDA Sets Target Action Date of Sept. 23; 13/03/2018 – Merck: First Filing Acceptance for an Anti-PD-1 Therapy in Cervical Cancer; 27/03/2018 – Merck KGaA Receives Fast-Track Designation for Tepotinib in Japan; 07/03/2018 – Merck KGaA Announces Positive Phase IIB Results for Evobrutinib in Relapsing Multiple Sclerosis; 15/04/2018 – Arab Finance: Mylan seeks deal for German Merck’s consumer products unit; 20/03/2018 – Phase III IMpower131 Study Showed Genentech’s TECENTRIQ (Atezolizumab) Plus Chemotherapy (Carboplatin and ABRAXANE) Reduced; 01/05/2018 – MERCK & CO SEES FY ADJ EPS $4.16 TO $4.28, SAW $4.08 TO $4.23; 23/04/2018 – Merck: EMA Validates Type II Variation for KEYTRUDA in Combination With Pemetrexed and Platinum Chemotherapy; 09/03/2018 – Onglyza Heart Failure Lawsuits Move Forward, As Federal Litigation Issues First Practice and Procedure Order, Bernstein Liebhard LLP Reports

More notable recent Chevron Corporation (NYSE:CVX) news were published by: Seekingalpha.com which released: “Alberto affecting Gulf oil production” on May 28, 2018, also Seekingalpha.com with their article: “FT: Exxon, Chevron accused over tax secrecy” published on June 06, 2018, Seekingalpha.com published: “Chevron starts second Wheatstone LNG production train” on June 15, 2018. More interesting news about Chevron Corporation (NYSE:CVX) were released by: Fool.com and their article: “ConocoPhillips and Chevron Stock Win Analysts’ Favor: What You Need to Know” published on June 11, 2018 as well as Seekingalpha.com‘s news article titled: “Chevron: Why I See Further Upside” with publication date: June 14, 2018.

Investors sentiment decreased to 0.9 in Q1 2018. Its down 0.09, from 0.99 in 2017Q4. It is negative, as 55 investors sold CVX shares while 718 reduced holdings. 114 funds opened positions while 579 raised stakes. 1.19 billion shares or 0.11% more from 1.19 billion shares in 2017Q4 were reported. Coho Prtnrs Ltd has 2.73% invested in Chevron Corporation (NYSE:CVX) for 910,359 shares. Bluemountain Cap Mngmt Limited Liability owns 572 shares or 0% of their US portfolio. Rice Hall James & Assocs Limited invested in 5,875 shares or 0.03% of the stock. Exchange Capital stated it has 0.25% of its portfolio in Chevron Corporation (NYSE:CVX). Sumitomo Mitsui Holdings stated it has 0.85% in Chevron Corporation (NYSE:CVX). Deutsche National Bank Ag holds 6.62 million shares or 0.49% of its portfolio. Congress Asset Management Ma holds 362,318 shares. Cedar Hill Associates Ltd Company reported 0.17% stake. Iowa Bankshares reported 39,935 shares. 1.14M were reported by Aviva Public Ltd Company. Sterling Cap Mngmt Ltd Liability Co has 105,022 shares for 0.11% of their portfolio. Dean Invest Assoc Ltd accumulated 59,827 shares or 1.01% of the stock. Georgia-based Marshwinds Advisory Company has invested 1.18% in Chevron Corporation (NYSE:CVX). Guinness Asset Management has invested 1.88% in Chevron Corporation (NYSE:CVX). Hodges Management holds 15,394 shares.

Since April 17, 2018, it had 0 buys, and 10 insider sales for $50.35 million activity. $16.64M worth of Chevron Corporation (NYSE:CVX) was sold by Wirth Michael K. The insider Geagea Joseph C sold 12,000 shares worth $1.54M. $1.23M worth of Chevron Corporation (NYSE:CVX) shares were sold by JOHNSON JAMES WILLIAM. Shares for $17.55M were sold by Yarrington Patricia E. 25,500 Chevron Corporation (NYSE:CVX) shares with value of $3.31M were sold by Pate R. Hewitt.

Among 36 analysts covering Chevron Corporation (NYSE:CVX), 28 have Buy rating, 0 Sell and 8 Hold. Therefore 78% are positive. Chevron Corporation had 125 analyst reports since August 4, 2015 according to SRatingsIntel. The company was maintained on Tuesday, December 15 by Cowen & Co. On Thursday, August 24 the stock rating was maintained by Piper Jaffray with “Buy”. The stock of Chevron Corporation (NYSE:CVX) earned “Sector Perform” rating by RBC Capital Markets on Wednesday, March 9. The firm earned “Buy” rating on Tuesday, January 23 by Piper Jaffray. The rating was maintained by RBC Capital Markets on Friday, August 18 with “Sell”. The firm has “Neutral” rating by Macquarie Research given on Wednesday, June 21. The firm has “Sector Perform” rating by RBC Capital Markets given on Friday, February 9. The company was initiated on Tuesday, September 13 by BMO Capital Markets. Howard Weil upgraded Chevron Corporation (NYSE:CVX) on Monday, December 14 to “Sector Outperform” rating. The stock of Chevron Corporation (NYSE:CVX) earned “Buy” rating by Societe Generale on Friday, February 2.

Kahn Brothers Group Inc, which manages about $627.75 billion US Long portfolio, decreased its stake in Novartis Adr (NYSE:NVS) by 4,600 shares to 22,010 shares, valued at $1.78B in 2018Q1, according to the filing. It also reduced its holding in Citigroup by 33,416 shares in the quarter, leaving it with 948,482 shares, and cut its stake in Genie Energy.

Banced Corp, which manages about $56.35M US Long portfolio, decreased its stake in Altria Group Inc (NYSE:MO) by 5,260 shares to 13,071 shares, valued at $814,000 in 2018Q1, according to the filing.

Investors sentiment increased to 1 in 2018 Q1. Its up 0.06, from 0.94 in 2017Q4. It improved, as 72 investors sold MRK shares while 603 reduced holdings. 114 funds opened positions while 561 raised stakes. 1.91 billion shares or 1.08% less from 1.93 billion shares in 2017Q4 were reported. 25,300 are owned by Capital Ca. Farr Miller & Washington Limited Liability Com Dc stated it has 0.07% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Ellington Mgmt Gru Ltd Limited Liability Company has invested 0.08% in Merck & Co., Inc. (NYSE:MRK). Invesco stated it has 0.4% in Merck & Co., Inc. (NYSE:MRK). First Republic Invest Mgmt holds 1.03 million shares. 80,094 were reported by Hamel. Parsec Mgmt accumulated 10,300 shares. Whittier Tru Of Nevada Inc holds 170,417 shares or 0.76% of its portfolio. Moreover, Westwood Holdings Gp has 0.01% invested in Merck & Co., Inc. (NYSE:MRK) for 20,189 shares. Marble Harbor Invest Counsel Limited holds 0.67% or 62,524 shares. Moreover, Cap Intll Ca has 0.14% invested in Merck & Co., Inc. (NYSE:MRK) for 17,800 shares. Foyston Gordon & Payne has invested 0.76% in Merck & Co., Inc. (NYSE:MRK). Df Dent & Communications Incorporated accumulated 26,288 shares. Northern Corp holds 0.47% or 33.32M shares. Bb&T holds 0.58% or 559,488 shares.

Among 24 analysts covering Merck & Co. Inc. (NYSE:MRK), 21 have Buy rating, 0 Sell and 3 Hold. Therefore 88% are positive. Merck & Co. Inc. had 90 analyst reports since August 13, 2015 according to SRatingsIntel. SunTrust maintained Merck & Co., Inc. (NYSE:MRK) rating on Friday, July 28. SunTrust has “Buy” rating and $7300 target. The stock has “Buy” rating by Goldman Sachs on Monday, April 23. The rating was initiated by Societe Generale with “Buy” on Wednesday, April 6. The firm has “Buy” rating by UBS given on Monday, October 30. The rating was upgraded by Barclays Capital to “Overweight” on Tuesday, December 1. The stock has “Buy” rating by Citigroup on Monday, October 30. As per Wednesday, July 19, the company rating was maintained by BMO Capital Markets. On Wednesday, September 30 the stock rating was initiated by Societe Generale with “Hold”. Barclays Capital maintained Merck & Co., Inc. (NYSE:MRK) rating on Friday, September 9. Barclays Capital has “Overweight” rating and $72 target. The company was upgraded on Monday, March 12 by Leerink Swann.

Merck & Co., Inc. (NYSE:MRK) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *